BACKGROUND Epidemiological studies suggest considerable overlap between functional dyspepsia (FD) and irritable bowel syndrome (IBS). To date, no surveys have been performed to investigate the clinical overlap between these two disorders using Rome III criteria. Our aim was to investigate the prevalence and risk factors for the overlap of FD and IBS based on Rome III criteria in a large clinica...

Scarce data exist concerning the prevalence of irritable bowel syndrome in adolescence. Changes in lifestyle, presence of stressors and psychological vulnerability during this stage of life place adolescents in the risk group for irritable bowel syndrome. The aim of this study is to determine the prevalence of irritable bowel syndrome in adolescents who are about to begin their university studi...

AIM Interest in functional bowel disorders (FBDs) and faecal incontinence (FI) has increased amongst coloproctologists. The study aimed to assess the prevalence of FBDs and FI (including its severity) among Australian primary healthcare seekers using objective criteria. METHOD A cross-sectional survey was conducted in a primary care setting in Sydney, Australia. A self-administered questionna...

aim and background: considering the high frequency of anxiety and depressive symptoms in irritable bowel syndrome (ibs) patients, selective serotonin reuptake inhibitors (ssris) are recommended by some gastroenterologists for treatment. in this study, the efficacy of fluvoxamine on severity of symptoms and quality of life in ibs patients was assessed. methods and materials: a randomized, double...

BACKGROUND Gastrointestinal symptoms are one of the most common non-motor features of Parkinson's disease (PD). Recently, a report from Taiwan revealed that irritable bowel syndrome (IBS) may be associated with an increased risk of developing PD; however, the prevalence of IBS in PD patients has not been fully evaluated. Rome III criteria are widely assessed with a questionnaire to determine fu...

BACKGROUND/AIMS In this study, we aimed to provide the usage of the Rome III criteria for irritable bowel syndrome (IBS) in the healthcare field by conducting validity and reliability studies in Turkey and to facilitate diagnosis of these patients. MATERIALS AND METHODS Item analysis of the Rome III criteria was performed, and the test was applied to 79 patients after their consistency had be...

Objective The aim of the present study is to assess the difference in the detection rates of small-bowel lesions in chronic abdominal pain (CAP) patients with irritable bowel syndrome (IBS) and non-IBS. Patients Ninety-nine CAP patients who were scheduled to undergo capsule endoscopy (CE) to investigate their abdominal symptoms were included in this study. Among the subjects, 34 patients fulfil...

Irritable bowel syndrome (IBS) is a persistent and relapsing functional gastrointestinal disorder. The Rome III criteria in children and adults are required in diagnosing IBS. The criteria include recent abdominal pain or discomfort present in three or more days/months with two or more of the following changes related to bowel movements: symptoms improving with defecation; excretion frequency c...

Aim: evaluation of the effectiveness nutraceutical “Standard Zdorovia: Gastro” (“SZ Gastro”) in treatment patients with irritable bowel syndrome (IBS). Materials and methods. 52 (62 % women) diagnosed IBS combination functional dyspepsia (FD) were included study divided into two groups. Both groups received basic therapy according to guidelines. The experimental group as add-on “SZ (containing ...